Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
124.00
+5.72 (4.84%)
Jul 13, 2026, 3:30 PM IST
NSE:LOTUSEYE Revenue
In the fiscal year ending March 31, 2026, Lotus Eye Hospital and Institute had annual revenue of 537.14M INR with 8.38% growth. Lotus Eye Hospital and Institute had revenue of 136.09M in the quarter ending March 31, 2026, with 18.21% growth.
Revenue
537.14M
Revenue Growth
+8.38%
P/S Ratio
4.58
Revenue / Employee
1.54M
Employees
348
Market Cap
2.46B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 537.14M | 41.52M | 8.38% |
| Mar 31, 2025 | 495.63M | 13.53M | 2.81% |
| Mar 31, 2024 | 482.10M | 11.66M | 2.48% |
| Mar 31, 2023 | 470.44M | 81.34M | 20.90% |
| Mar 31, 2022 | 389.10M | 65.51M | 20.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indraprastha Medical Corporation | 14.83B |
| Shalby | 11.41B |
| Artemis Medicare Services | 10.81B |
| GPT Healthcare | 4.73B |
| Max India | 2.13B |
| Unihealth Hospitals | 1.32B |
| Vaidya Sane Ayurved Laboratories | 1.07B |
| Maitreya Medicare | 448.50M |